Literature DB >> 21532099

Receiver operating characteristic (ROC) curve for medical researchers.

Rajeev Kumar1, Abhaya Indrayan.   

Abstract

Sensitivity and specificity are two components that measure the inherent validity of a diagnostic test for dichotomous outcomes against a gold standard. Receiver operating characteristic (ROC) curve is the plot that depicts the trade-off between the sensitivity and (1-specificity) across a series of cut-off points when the diagnostic test is continuous or on ordinal scale (minimum 5 categories). This is an effective method for assessing the performance of a diagnostic test. The aim of this article is to provide basic conceptual framework and interpretation of ROC analysis to help medical researchers to use it effectively. ROC curve and its important components like area under the curve, sensitivity at specified specificity and vice versa, and partial area under the curve are discussed. Various other issues such as choice between parametric and non-parametric methods, biases that affect the performance of a diagnostic test, sample size for estimating the sensitivity, specificity, and area under ROC curve, and details of commonly used softwares in ROC analysis are also presented.

Mesh:

Year:  2011        PMID: 21532099     DOI: 10.1007/s13312-011-0055-4

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  156 in total

Review 1.  Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation.

Authors:  Karimollah Hajian-Tilaki
Journal:  Caspian J Intern Med       Date:  2013

2.  Factor structure and psychometric properties of the Italian version of the Gambling Related Cognitions Scale (GRCS-I).

Authors:  Paolo Iliceto; Emanuele Fino; Camillo Cammarota; Eleni Giovani; Francesca Petrucci; Marta Desimoni; Ugo Sabatello; Gabriella Candilera; Tian Po Oei
Journal:  J Gambl Stud       Date:  2015-03

3.  In vivo assessment of caries excavation with a fluorescence camera compared to direct bacteriological sampling and quantitative analysis using flow cytometry.

Authors:  Richard Stoll; Beata Urban-Klein; Paul Giacomin; Alex Loukas; Anahita Jablonski-Momeni
Journal:  Lasers Med Sci       Date:  2013-10-19       Impact factor: 3.161

4.  Evidence Based Emergency Medicine; Part 5 Receiver Operating Curve and Area under the Curve.

Authors:  Saeed Safari; Alireza Baratloo; Mohamed Elfil; Ahmed Negida
Journal:  Emerg (Tehran)       Date:  2016

5.  Anthropometric discriminators of type 2 diabetes among White and Black American adults.

Authors:  Dale S Hardy; Devita T Stallings; Jane T Garvin; Francine C Gachupin; Hongyan Xu; Susan B Racette
Journal:  J Diabetes       Date:  2016-07-12       Impact factor: 4.006

6.  Evaluation of cone-beam computed tomography diagnostic image quality using cluster signal-to-noise analysis.

Authors:  Warangkana Weerawanich; Mayumi Shimizu; Yohei Takeshita; Kazutoshi Okamura; Shoko Yoshida; Gainer R Jasa; Kazunori Yoshiura
Journal:  Oral Radiol       Date:  2018-03-15       Impact factor: 1.852

7.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

8.  Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Authors:  Volkert B Wreesmann; Nora Katabi; Frank L Palmer; Pablo H Montero; Jocelyn C Migliacci; Mithat Gönen; Diane Carlson; Ian Ganly; Jatin P Shah; Ronald Ghossein; Snehal G Patel
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

Review 9.  Sample size estimation in epidemiologic studies.

Authors:  Karimollah Hajian-Tilaki
Journal:  Caspian J Intern Med       Date:  2011

10.  Reliability and validity of the timed 360° turn test in people with Parkinson's disease.

Authors:  Fatih Soke; Arzu Guclu-Gunduz; Taskin Ozkan; Cagla Ozkul; Cagri Gulsen; Bilge Kocer
Journal:  Eur Geriatr Med       Date:  2020-01-10       Impact factor: 1.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.